Patents by Inventor Jon Charles Lorenz

Jon Charles Lorenz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERMEDIATE COMPOUNDS AND METHODS
    Publication number: 20230183178
    Abstract: The present invention relates to compounds of (II) and an acceptable salt or hydrate thereof method of making same.
    Type: Application
    Filed: February 9, 2023
    Publication date: June 15, 2023
    Inventors: Phouvieng BEYER, Jason A. BRAZZILLO, Magnus ERIKSSON, Jon Charles LORENZ, Laurence J. NUMMY, Sonia RODRIGUEZ, Jolaine SAVOIE, Kanwar Pal Singh SIDHU, Joshua D. SIEBER, Thomas Gabriel TAMPONE, Zhulin TAN, Jun WANG, Li ZHANG, Weitong DONG, Pengtao ZHANG
  • Intermediate compounds and methods
    Patent number: 11603354
    Abstract: The present invention relates to compounds of (II) and an acceptable salt or hydrate thereof method of making same.
    Type: Grant
    Filed: July 14, 2021
    Date of Patent: March 14, 2023
    Inventors: Phouvieng Beyer, Jason A. Brazzillo, Weitong Dong, Magnus Eriksson, Jon Charles Lorenz, Laurence J. Nummy, Sonia Rodriguez, Jolaine Savoie, Kanwar Pal Singh Sidhu, Joshua D. Sieber, Thomas Gabriel Tampone, Zhulin Tan, Jun Wang, Li Zhang, Pengtao Zhang
  • INTERMEDIATE COMPOUNDS AND METHODS
    Publication number: 20210340101
    Abstract: The present invention relates to compounds of (II) and an acceptable salt or hydrate thereof method of making same.
    Type: Application
    Filed: July 14, 2021
    Publication date: November 4, 2021
    Inventors: Phouvieng BEYER, Jason A. BRAZZILLO, Weitong DONG, Magnus ERIKSSON, Jon Charles LORENZ, Laurence J. NUMMY, Sonia RODRIGUEZ, Jolaine SAVOIE, Kanwar Pal Singh SIDHU, Joshua D. SIEBER, Thomas Gabriel TAMPONE, Zhulin TAN, Jun WANG, Li ZHANG, Pengtao ZHANG
  • INTERMEDIATE COMPOUNDS AND METHODS
    Publication number: 20200369611
    Abstract: The present invention relates to compounds of (II) and an acceptable salt or hydrate thereof method of making same.
    Type: Application
    Filed: July 30, 2018
    Publication date: November 26, 2020
    Inventors: Phouvieng BEYER, Jason A. BRAZZILLO, Magnus ERIKSSON, Jon Charles LORENZ, Laurence J. NUMMY, Sonia RODRIGUEZ, Jolaine SAVOIE, Kanwar Pal Singh SIDHU, Joshua D. SIEBER, Thomas Gabriel TAMPONE, Zhulin TAN, June WANG, Li ZHANG
  • Electronically tuned ligands for asymmetric hydrogenation
    Patent number: 8212049
    Abstract: Disclosed is a new class of chiral bidentate ligands capable of performing asymmetric hydrogenation. Also disclosed are processes of performing asymmetric hydrogenation the chiral bidentate ligands.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: July 3, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl Alan Busacca, Jon Charles Lorenz
  • Process for preparing acyclic HCV protease inhibitors
    Patent number: 8101765
    Abstract: Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection: The disclosed processes use SNAr-type coupling reactions between peptidic compounds having a hydroxyproline moiety of the following formula: and halogenated or sulfonated bromoquinoline compounds.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: January 24, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl Alan Busacca, Rogelio Perez Frutos, Nizar Haddad, Suresh R. Kapadia, Jon Charles Lorenz, Anjan Saha, Chris Hugh Senanayake, Xudong Wei
  • Electronically Tuned Ligands For Asymmetric Hydrogenation
    Publication number: 20110257393
    Abstract: Disclosed is a new class of chiral bidentate ligands capable of performing asymmetric hydrogenation. Also disclosed are processes of performing asymmetric hydrogenation the chiral bidentate ligands.
    Type: Application
    Filed: June 28, 2011
    Publication date: October 20, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Carl Alan BUSACCA, Jon Charles LORENZ
  • Process for preparing acyclic HCV protease inhibitors
    Patent number: 8017771
    Abstract: Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection: The disclosed processes use SNAr-type coupling reactions between peptidic compounds having a hydroxyproline moiety of the following formula: and halogenated or sulfonated bromoquinoline compounds.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: September 13, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl Alan Busacca, Rogelio Perez Frutos, Nizar Haddad, Suresh R. Kapadia, Jon Charles Lorenz, Anjan Saha, Chris Hugh Senanayake, Xudong Wei
  • Electronically tuned ligands for asymmetric hydrogenation
    Patent number: 7994335
    Abstract: Disclosed is a new class of chiral bidentate ligands capable of performing asymmetric hydrogenation. Also disclosed are processes of performing asymmetric hydrogenation the chiral bidentate ligands.
    Type: Grant
    Filed: November 20, 2007
    Date of Patent: August 9, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl Alan Busacca, Jon Charles Lorenz
  • Electronically Tuned Ligands For Asymmetric Hydrogenation
    Publication number: 20100041898
    Abstract: Disclosed is a new class of chiral bidentate ligands capable of performing asymmetric hydrogenation. Also disclosed are processes of performing asymmetric hydrogenation the chiral bidentate ligands.
    Type: Application
    Filed: November 20, 2007
    Publication date: February 18, 2010
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Carl Alan Busacca, Jon Charles Lorenz
  • PROCESS FOR PREPARING ACYCLIC HCV PROTEASE INHIBITORS
    Publication number: 20090124809
    Abstract: Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection: The disclosed processes use SNAr-type coupling reactions between peptidic compounds having a hydroxyproline moiety of the following formula: and halogenated or sulfonated bromoquinoline compounds.
    Type: Application
    Filed: January 16, 2009
    Publication date: May 14, 2009
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Carl Alan BUSACCA, Rogelio Perez FRUTOS, Nizar HADDAD, Suresh R. KAPADIA, Jon Charles LORENZ, Anjan SAHA, Chris Hugh SENANAYAKE, Xudong WEI
  • PROCESS FOR PREPARING ACYCLIC HCV PROTEASE INHIBITORS
    Publication number: 20090124808
    Abstract: Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection: The disclosed processes use SNAr-type coupling reactions between peptidic compounds having a hydroxyproline moiety of the following formula: and halogenated or sulfonated bromoquinoline compounds.
    Type: Application
    Filed: January 16, 2009
    Publication date: May 14, 2009
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Carl Alan BUSACCA, Rogelio Perez FRUTOS, Nizar HADDAD, Suresh R. KAPADIA, Jon Charles LORENZ, Anjan SAHA, Chris Hugh SENANAYAKE, Xudong WEI
  • Process for preparing acyclic HCV protease inhibitors
    Patent number: 7514557
    Abstract: Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection: The disclosed processes use SNAr-type coupling reactions between peptidic compounds having a hydroxyproline moiety of the following formula: and halogenated or sulfonated bromoquinoline compounds.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: April 7, 2009
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl Alan Busacca, Rogelio Perez Frutos, Nizar Haddad, Suresh R. Kapadia, Jon Charles Lorenz, Anjan Saha, Chris Hugh Senanayake, Xudong Wei
  • Dipeptide synthesis
    Patent number: 7186827
    Abstract: Disclosed are processes of making dipeptide compounds of formula(I) as further described in the detailed description section:
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: March 6, 2007
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Carl Alan Busacca, Nizar Haddad, Suresh R. Kapadia, Lana Smith Keenan, Jon Charles Lorenz, Chris Hugh Senanayake, Xudong Wei